Instruction for use: Topalkan

Pharmacological group

Antacids

Nosological classification (ICD-10)

K21.0 Gastro-oesophageal reflux with oesophagitis

Reflux gastritis, Reflux esophagitis, Erosive and ulcerative esophagitis

K25 Gastric ulcer

Helicobacter pylori, Pain syndrome in gastric ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, Inflammation of the gastric mucosa, Inflammation of the gastrointestinal mucosa, Benign gastric ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Aggravation gastroduodenita on the background of peptic ulcer, Exacerbation of peptic ulcer, The aggravation of gastric ulcer, The organic gastrointestinal disease, Peptic ulcer of the stomach and duodenum, Postoperative gastric ulcer, Recurrent ulcers, Symptomatic gastric ulcers, Chronic inflammatory disease of the upper gastrointestinal tract, associated with Helicobacter pylori, Helicobacter pylori eradication, Erosive and ulcerative lesions of the stomach, Erosive lesions of the stomach, The erosion of the gastric mucosa, Peptic ulcer disease, Stomach ulcer, Gastric lesion, Ulcerative lesions of the stomach, Symptomatic ulcers of the stomach and duodenum

K26 Duodenal Ulcer

Pain with duodenal ulcer, Pain syndrome in gastric ulcer and duodenal ulcer, The disease of the stomach and duodenum, asotsiirovannoe with Helicobacter pylori, Exacerbation of peptic ulcer, The worsening of duodenal ulcer, Peptic ulcer of the stomach and duodenum, Relapse of duodenal ulcers, Symptomatic ulcers of the stomach and duodenum, Helicobacter pylori eradication, Erosive and ulcerative lesions of the duodenum, Erosive-ulcerative lesions of duodenal ulcers associated with Helicobacter pylori, Erosive lesions of the duodenum, Duodenal ulcer, Ulcerative lesions of the duodenum]

K29 Gastritis and duodenitis

Aggravation gastroduodenita on the background of peptic ulcer, duodenitis

R12 Heartburn

Composition and form of release

1 tablet for chewing contains alginic acid 200 mg, colloidal aluminum hydroxide 30 mg, magnesium hydrogencarbonate 40 mg and hydrated silicon 130 mg, packaged 42 pcs .; 1 packet with powder for the preparation of a suspension for the inside of these components - 400, 60, 80 and 260 mg respectively, in the package 21 pcs.

pharmachologic effect

Pharmacological action - enveloping, antacid.

Indication

Reflux-esophagitis, erosive-ulcerative diseases of the esophagus, acute and chronic gastritis (in the phase of exacerbation), peptic ulcer of the stomach and duodenum in the phase of exacerbation, heartburn.

Contraindications

Hypersensitivity.

Side effects

Reduction of the phosphorus content in the body (with long-term intake of high doses).

Interaction

Reduces the absorption of indomethacin, tetracycline, digoxin, isoniazid, holinomimetikov.

Dosing and Administration

Inside, after eating 2 tablets (carefully chew) or 1 packet (pour into a glass, add water, mix until a suspension) 3 times a day.

Precautionary measures

When appointing patients with diabetes should take into account that 1 tablet contains 0.88 grams, and in 1 sachet - 1.76 g of glucose.

Storage conditions

Keep out of the reach of children.